» Articles » PMID: 32824087

Soy Isoflavone Genistein Inhibits an Axillary Osmidrosis Risk Factor ABCC11: In Vitro Screening and Fractional Approach for ABCC11-Inhibitory Activities in Plant Extracts and Dietary Flavonoids

Overview
Journal Nutrients
Date 2020 Aug 23
PMID 32824087
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Axillary osmidrosis (AO) is a common chronic skin condition characterized by unpleasant body odors emanating from the armpits, and its aetiology is not fully understood. AO can seriously impair the psychosocial well-being of the affected individuals; however, no causal therapy has been established for it other than surgical treatment. Recent studies have revealed that human ATP-binding cassette transporter C11 (ABCC11) is an AO risk factor when it is expressed in the axillary apocrine glands-the sources of the offensive odors. Hence, identifying safe ways to inhibit ABCC11 may offer a breakthrough in treating AO. We herein screened for ABCC11-inhibitory activities in 34 natural products derived from plants cultivated for human consumption using an in vitro assay system to measure the ABCC11-mediated transport of radiolabeled dehydroepiandrosterone sulfate (DHEA-S-an ABCC11 substrate). The water extract of soybean () was found to exhibit the strongest transport inhibition. From this extract, via a fractionation approach, we successfully isolated and identified genistein, a soy isoflavone, as a novel ABCC11 inhibitor with a half-maximal inhibitory concentration value of 61.5 μM. Furthermore, we examined the effects of other dietary flavonoids on the ABCC11-mediated DHEA-S transport to uncover the effects of these phytochemicals on ABCC11 function. While further human studies are needed, our findings here about the natural compounds will help develop a non-surgical therapy for AO.

Citing Articles

Functional characterization of variants in human ABCC11, an axillary osmidrosis risk factor.

Toyoda Y, Matsuo H, Takada T Hum Cell. 2024; 37(4):1070-1079.

PMID: 38750405 DOI: 10.1007/s13577-024-01074-x.


New insight into the management of renal excretion and hyperuricemia: Potential therapeutic strategies with natural bioactive compounds.

Yang B, Xin M, Liang S, Xu X, Cai T, Dong L Front Pharmacol. 2022; 13:1026246.

PMID: 36483739 PMC: 9723165. DOI: 10.3389/fphar.2022.1026246.


Identification of Inhibitory Activities of Dietary Flavonoids against URAT1, a Renal Urate Re-Absorber: In Vitro Screening and Fractional Approach Focused on Rooibos Leaves.

Toyoda Y, Takada T, Saito H, Hirata H, Ota-Kontani A, Tsuchiya Y Nutrients. 2022; 14(3).

PMID: 35276934 PMC: 8839210. DOI: 10.3390/nu14030575.


Binding mode analysis of ABCA7 for the prediction of novel Alzheimer's disease therapeutics.

Namasivayam V, Stefan K, Pahnke J, Stefan S Comput Struct Biotechnol J. 2022; 19:6490-6504.

PMID: 34976306 PMC: 8666613. DOI: 10.1016/j.csbj.2021.11.035.

References
1.
Cao Z, Green-Johnson J, Buckley N, Lin Q . Bioactivity of soy-based fermented foods: A review. Biotechnol Adv. 2018; 37(1):223-238. DOI: 10.1016/j.biotechadv.2018.12.001. View

2.
Miyata H, Takada T, Toyoda Y, Matsuo H, Ichida K, Suzuki H . Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical Situations. Front Pharmacol. 2017; 7:518. PMC: 5187494. DOI: 10.3389/fphar.2016.00518. View

3.
Toyoda Y, Takada T, Miyata H, Ishikawa T, Suzuki H . Regulation of the Axillary Osmidrosis-Associated ABCC11 Protein Stability by N-Linked Glycosylation: Effect of Glucose Condition. PLoS One. 2016; 11(6):e0157172. PMC: 4900533. DOI: 10.1371/journal.pone.0157172. View

4.
Yang Z, Kulkarni K, Zhu W, Hu M . Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME. Anticancer Agents Med Chem. 2012; 12(10):1264-80. PMC: 4010305. DOI: 10.2174/187152012803833107. View

5.
Toyoda Y, Takada T, Suzuki H . Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications. Front Pharmacol. 2019; 10:208. PMC: 6411714. DOI: 10.3389/fphar.2019.00208. View